Share this post on:

Product Name :
Recombinant human erythropoietin (CHO Cell), Shanghai Chemo Wanbang Biophama Co Ltd

Search keywords :
EPOR

drugId :
null

Target Vo:
Erythropoietin receptor

Target Vo Short Name :
EpoR

Moa_Name:
Erythropoietin receptor agonists

First Approval Country :
Mainland China

First Approval Date Filter:
2023

Origin Company_Name :
Shanghai Chemo Wanbang Biophama Co Ltd

Active Company_Name :
Shanghai Chemo Wanbang Biophama Co Ltd

Active Indication_Name:
Anemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Fos Rabbit mAb Formula
Androgen receptor Rabbit mAb Purity
FCGR1A Antibody: FCGR1A Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-FCGR1A monoclonal antibody. FCGR1A Antibody can be used for: WB, IHC-P, FC expriments in human background without labeling.

Share this post on:

Author: Interleukin Related